ORIGINAL RESEARCH
Accepted on 11 Sep 2025
Breaking the Heterogeneity Barrier: A Robust Prognostic Signature for Survival Stratification and Immune Profiling in Triple-Negative Breast Cancer
doi 10.3389/fimmu.2025.1611917
- 190 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
9,091
Total downloads
44k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 01 Sep 2025
TGM2 Regulated by Transcription Factor NR3C1 Drives p38 MAPK-Mediated Tumor Progression and Immune Evasion in Lung Squamous Cell Carcinoma
doi 10.3389/fimmu.2025.1595907
- 114 views
CASE REPORT
Published on 14 Aug 2025
Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature
doi 10.3389/fimmu.2025.1616361
- 1,007 views
ORIGINAL RESEARCH
Published on 30 Jul 2025
Comprehensive analysis of regulatory B Cell related genes in prognosis and therapeutic response in lung adenocarcinoma
doi 10.3389/fimmu.2025.1595408
- 1,514 views
ORIGINAL RESEARCH
Published on 09 Jul 2025
CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
doi 10.3389/fimmu.2025.1589423
- 1,286 views
ORIGINAL RESEARCH
Published on 30 May 2025
GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma
doi 10.3389/fimmu.2025.1572757
- 2,414 views
ORIGINAL RESEARCH
Published on 30 May 2025
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
doi 10.3389/fimmu.2025.1553882
- 1,641 views
SYSTEMATIC REVIEW
Published on 26 May 2025
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1592761
- 1,455 views
SYSTEMATIC REVIEW
Published on 16 May 2025
Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1532343
- 1,382 views
REVIEW
Published on 08 May 2025
Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer
doi 10.3389/fimmu.2025.1554871
- 3,145 views
- 2 citations
ORIGINAL RESEARCH
Published on 08 May 2025
Toll-like receptor 3 activation enhances antitumor immune response in lung adenocarcinoma through NF-κB signaling pathway
doi 10.3389/fimmu.2025.1585747
- 1,389 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 Apr 2025
BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer
doi 10.3389/fimmu.2025.1562700
- 2,099 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: